Biểu hiện chuyển gen có thể đảo ngược giảm thiểu fratricide và cho phép sự đồng kích thích 4-1BB của tế bào T CAR hướng tới các khối u ác tính ở tế bào T

Savoldo, 2011, CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients, J Clin Invest, 121, 1822, 10.1172/JCI46110

Till, 2008, Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells, Blood, 112, 2261, 10.1182/blood-2007-12-128843

Jensen, 2010, Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans, Biol Blood Marrow Transplant, 16, 1245, 10.1016/j.bbmt.2010.03.014

Dotti, 2014, Design and development of therapies using chimeric antigen receptor-expressing T cells, Immunol Rev, 257, 107, 10.1111/imr.12131

Maude, 2014, Chimeric antigen receptor T cells for sustained remissions in leukemia, N Engl J Med, 371, 1507, 10.1056/NEJMoa1407222

Turtle, 2016, CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients, J Clin Invest, 126, 2123, 10.1172/JCI85309

Brentjens, 2013, CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia, Sci Transl Med, 5, 177ra38, 10.1126/scitranslmed.3005930

Lee, 2015, T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial, Lancet, 385, 517, 10.1016/S0140-6736(14)61403-3

Porter, 2011, Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia, N Engl J Med, 365, 725, 10.1056/NEJMoa1103849

Macintyre, 2011, Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism, Immunity, 34, 224, 10.1016/j.immuni.2011.01.012

Chi, 2012, Regulation and function of mTOR signalling in T cell fate decisions, Nat Rev Immunol, 12, 325, 10.1038/nri3198

Boomer, 2010, An enigmatic tail of CD28 signaling, Cold Spring Harb Perspect Biol, 2, a002436, 10.1101/cshperspect.a002436

Kawalekar, 2016, Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells, Immunity, 44, 380, 10.1016/j.immuni.2016.01.021

Hombach, 1998, An anti-CD30 chimeric receptor that mediates CD3-ζ-independent T-cell activation against Hodgkin's lymphoma cells in the presence of soluble CD30, Cancer Res, 58, 1116

Savoldo, 2007, Epstein Barr virus–specific cytotoxic T lymphocytes expressing the anti-CD30ζ artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease, Blood, 110, 2620, 10.1182/blood-2006-11-059139

Chu, 2014, CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma, Leukemia, 28, 917, 10.1038/leu.2013.279

Mamonkin, 2015, A T-cell–directed chimeric antigen receptor for the selective treatment of T-cell malignancies, Blood, 126, 983, 10.1182/blood-2015-02-629527

Krenciute, 2016, Characterization and functional analysis of scFv-based chimeric antigen receptors to redirect T cells to IL13Rα2-positive glioma, Mol Ther, 24, 354, 10.1038/mt.2015.199

Banerjee, 2010, Quantitative measurement of F-actin accumulation at the NK cell immunological synapse, J Immunol Methods, 355, 1, 10.1016/j.jim.2010.02.003

Mentlik, 2010, Rapid lytic granule convergence to the MTOC in natural killer cells is dependent on dynein but not cytolytic commitment, Mol Biol Cell, 21, 2241, 10.1091/mbc.e09-11-0930

Jang, 1998, Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-κB, Biochem Biophys Res Commun, 242, 613, 10.1006/bbrc.1997.8016

Pomerantz, 1999, NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase, EMBO J, 18, 6694, 10.1093/emboj/18.23.6694

So, 2011, Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells, Proc Natl Acad Sci USA, 108, 2903, 10.1073/pnas.1008765108

Dustin, 2000, The immunological synapse and the actin cytoskeleton: molecular hardware for T cell signaling, Nat Immunol, 1, 23, 10.1038/76877

Billadeau, 2007, Regulation of T-cell activation by the cytoskeleton, Nat Rev Immunol, 7, 131, 10.1038/nri2021

Springer, 1990, Adhesion receptors of the immune system, Nature, 346, 425, 10.1038/346425a0

Schmits, 1996, LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor, J Exp Med, 183, 1415, 10.1084/jem.183.4.1415

Roebuck, 1999, Regulation of intercellular adhesion molecule-1 (CD54) gene expression, J Leukoc Biol, 66, 876, 10.1002/jlb.66.6.876

Melotti, 2001, Activation of NF-kB mediates ICAM-1 induction in respiratory cells exposed to an adenovirus-derived vector, Gene Ther, 8, 1436, 10.1038/sj.gt.3301533

Gomes-Silva, 2017, Tonic 4-1BB costimulation in chimeric antigen receptors impedes T cell survival and is vector-dependent, Cell Rep, 21, 17, 10.1016/j.celrep.2017.09.015

Sharpe, 2009, Mechanisms of costimulation, Immunol Rev, 229, 5, 10.1111/j.1600-065X.2009.00784.x

Chen, 2013, Molecular mechanisms of T cell co-stimulation and co-inhibition, Nat Rev Immunol, 13, 227, 10.1038/nri3405

Watts, 2005, Tnf/Tnfr family members in costimulation of T cell responses, Annu Rev Immunol, 23, 23, 10.1146/annurev.immunol.23.021704.115839

Hernandez-Chacon, 2011, Co-stimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances anti-tumor effector function, J Immunother, 34, 236, 10.1097/CJI.0b013e318209e7ec

Kinashi, 2005, Intracellular signalling controlling integrin activation in lymphocytes, Nat Rev Immunol, 5, 546, 10.1038/nri1646

Dustin, 1989, T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1, Nature, 341, 619, 10.1038/341619a0

Parameswaran, 2005, Lack of ICAM-1 on APCs during T cell priming leads to poor generation of central memory cells, J Immunol, 175, 2201, 10.4049/jimmunol.175.4.2201

Cox, 2013, ICAM-1–dependent tuning of memory CD8 T-cell responses following acute infection, Proc Natl Acad Sci, 110, 1416, 10.1073/pnas.1213480110

Camacho, 2001, A key role for ICAM-1 in generating effector cells mediating inflammatory responses, Nat Immunol, 2, 523, 10.1038/88720

Dustin, 1986, Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1), J Immunol, 137, 245, 10.4049/jimmunol.137.1.245

Buckle, 1990, Human memory T cells express intercellular adhesion molecule-1 which can be increased by interleukin 2 and interferon-gamma, Eur J Immunol, 20, 337, 10.1002/eji.1830200216

Zumwalde, 2013, ICAM-1–dependent homotypic aggregates regulate CD8 T cell effector function and differentiation during T cell activation, J Immunol, 191, 3681, 10.4049/jimmunol.1201954

Shawler, 1988, Mechanisms of human CD5 modulation and capping induced by murine monoclonal antibody T101, Clin Immunol Immunopathol, 47, 219, 10.1016/0090-1229(88)90074-8

Lu, 2002, AP2 Adaptor complex-dependent internalization of CD5: differential regulation in T and B cells, J Immunol, 168, 5612, 10.4049/jimmunol.168.11.5612

Pulè, 2005, A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells, Mol Ther, 12, 933, 10.1016/j.ymthe.2005.04.016

Song, 2012, CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo, Blood, 119, 696, 10.1182/blood-2011-03-344275

Long, 2015, 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors, Nat Med, 21, 581, 10.1038/nm.3838

Ghosh, 2017, Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity, Nat Med, 23, 242, 10.1038/nm.4258